Young Model

Xerion Limited is an Australian-based specialty pharmaceutical company focused on revolutionising standard of care in dermatology through the development of innovative  therapies using botanical drug development.

The company’s product portfolio includes a robust pipeline of dermatological products being developed specifically for the US prescription market.


Xerion has already launched over the counter (OTC) products containing AMYCOT    in pharmacies throughout Australia and via e-commerce.


nailKALM    is TGA listed to treat fungal nail disease and early clinical evidence indicates potential for the treatment of acne, atopic dermatitis, psoriasis, rosacea and actinic keratosis (pre-basal cell carcinoma).